Hinweis-Modus ist eingeschaltet Ausschalten

159622 - Tibet Eastmoney CSI SH-HK-SZ Brand Name Drug Industry ETF (CNY) (CNE100005YZ1)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.
 
(%)
CNE100005YZ1
159622 ISIN
Exchange Traded Funds (ETF)
Fondstyp
Tibet Eastmoney Funds
Anbieter
-
NAV pro Aktie
21/04/2023
Startdatum
1 Wiederholungen pro Jahr
Ausschüttung von Dividenden
CEOXXX
CFI
159622
Ticker
Formed
Status
Equity
Investitionsobjekt
Healthcare
Sektor
China
Geographie
CSI Shanghai-Hong Kong-Shenzhen Innovative Drug Industry Index
Benchmark
0.55 %
Gesamtkostenquote
Physical
Replikationsmethode
Nein
UCITS
Passive (Index)
Management Style

Letzte Daten zum
Zum Vergleichen hinzufügen

Kurse (159622)

Entdecken Sie die umfangreichste Datenbank

1 000 000

Anleihen weltweit

80 234

Aktien

167 970

ETF & Funds

80 000

Indizes

Verwalten Sie Ihr Portfolio auf effizienteste Weise

  • Bond-Screener
  • Watchlist
  • Excel-Add-In

Kurs-Dynamik

Fund profile

The Tibet Eastmoney CSI SH-HK-SZ Brand Name Drug Industry ETF seeks to replicate as closely as possible the price and yield performance of the CSI Shanghai-Hong Kong-Shenzhen Innovative Drug Industry Index and invests in a portfolio comprised primarily of Chinese healthcare companies

159622 profile

The Tibet Eastmoney CSI SH-HK-SZ Brand Name Drug Industry ETF (CNY) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Healthcare sector located in China. The Tibet Eastmoney Funds fund’s base currency is CNY and the share class was registered 21.04.2023 with unique ISIN - CNE100005YZ1. Main exchange is Shenzhen SE and ticker symbol is 159622. The total expense ratio is 0.55%. The Tibet Eastmoney CSI SH-HK-SZ Brand Name Drug Industry ETF (CNY) pays dividends 1 time(s) per year.

Andere ETFs und Fonds dieses Anbieters

Ähnliche Etf & Fonds

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} Mio.
    NAV
    {{ item.expense_ratio }}
    Gesamtkostenquote
Sie müssen sich registrieren , um Zugriff zu erhalten.